Synchronous endometrial and ovarian cancer and its recurrent risk factors: Case series

Cancer Treat Res Commun. 2023:36:100731. doi: 10.1016/j.ctarc.2023.100731. Epub 2023 Jun 25.

Abstract

Background: Synchronous endometrial and ovarian cancer (SEOC) is a relatively rare entity with indistinct clinical manifestation but have a better prognosis compared to metastatic malignancy of each organ. The aim of the study is to determine the prognosis and factors associated with recurrence of SEOC.

Methods: This case-series study was performed on 37 histologically confirmed SEOC, diagnosed and treated in our tertiary hospital from March 2009 to September 2021. Disease-free survival (DFS) and overall survival (OS) rates following indicated procedure were calculated using the Kaplan-Meier method. Univariate and multivariate Cox regression analysis were used to determine risk factors of recurrence.

Results: The mean age of participants was 49.38 (age range: 26-78). The most common complaints and symptoms were abdominal pain (40.5%), followed by abnormal uterine bleeding (29.7%). Most common histological presentation was endometroid type for both ovarian (46%) and endometrial (97.3%) cancers. Over the mean follow-up period of 85.54 months, 11 patients developed recurrence without mortality. Non-endometrioid histology of ovarian cancer, higher grade and stage of ovarian cancer, and omentum invasion were significantly associated with worse DFS in unvariate analysis. Lymphovascular invasion was the sole predictor of DFS in multivariate analysis.

Conclusion: While this study was not able to investigate the risk factors of overall survival associated with SEOC, the results of this study provides an overview of clinicopathological presentation of the disease and emphasizes the importance of lymphovascular invasion in determining prognosis and DFS in SEOC.

Keywords: Carcinoma; Endometrial neoplasms; Ovarian epithelial; Risk factor.

MeSH terms

  • Adult
  • Aged
  • Carcinoma, Endometrioid* / pathology
  • Carcinoma, Ovarian Epithelial
  • Endometrial Neoplasms* / pathology
  • Female
  • Humans
  • Middle Aged
  • Ovarian Neoplasms* / pathology
  • Retrospective Studies